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ABSTRACT		The	current	study	was	carried	out	to	evaluate	the	cardio	protective	activity	of	Pulicaria	Wightiana	against	Isoproterenol	(ISO)	induced	myocardial	infarction	(MI).	Pretreatment	to	the	different	groups	were	given	for	30	days	and	ISO	was	administered	at	last	two	days	with	an	interval	of	24	hrs.	Due	to	chronic	ionotropy	ISO	induces	MI.	Blood	was	collected	at	the	last	day	of	experimental	period	and	biomarkers	were	observed.	The	results	indicate	that	the	extract	exhibited	significant	cardioprotective	activity.	 	  
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INTRODUCTION	Myocardial	 Infarction	 (MI)	 is	 the	acute	condition	of	necrosis	of	the	myocardium	that	occurs	a	result	of	im-balance	between	coronary	blood	supply	and	myocar-dium	demand.	Myocardial	infarction	normally	known	as	a	heart	attack,	happens	when	flow	of	blood	reduces	or	stops	to	a	part	of	the	heart,	then	causes	damage	to	the	muscle	[1]	.	Isoproterenol	drug	(ISO)	is	a	artificial	catecholamine	which	 is	a	β-adrenergic	agonist;	on	high	concentra-tions	 it	 depletes	 the	 endogenous	 stores,	 energy	 re-serves	of	cardiac	myocytes	and	results	in	biochemi-
cal,	structural	changes	which	are	responsible	for	irre-versible	damage.	Chemically,	ISO	is	an	L-B-(3,	4-dihy-droxyphenyl)-or-isopropyl	 amino	 ethanol	 hydro-chloride	[2].	The	 pathophysiological	 changes	 as	 induced	 by	 ISO	mimics	to	a	larger	extent	with	those	occurring	in	hu-mans	[3].	ISO	is	a	β-	adrenergic	receptor	agonist	that	increases	cytosolic	cAMP[4].	The	drug	hormone	recep-tor	 complex	 initiates	 enzyme	 adenyl	 cyclase	 on	 the	internal	surface	of	the	plasma	membrane	of	the	spe-cific	cells.	This	accelerates	the	intracellular	formation	of	cyclic	adenosine	monophosphate	(cyclic	AMP),	the	second	“messenger”	which	then	stimulates	or	inhibits	various	metabolic	 or	 physiological	 processes	 [5],	 [6]	 .	ISO	increase	the	activities	of	Raf	-I	kinase	and	MAP	ki-nase,	which	 accelerate	 phenylalanine	 incorporation	into	proteins	[7],	leading	to	cardiomyocyte	hypertro-phy[8].	ISO	causes	increase	in	oxidative	stress	resulting	in	in-crease	free	radical	activity.	ISO	induced	biochemical	&	 histopathological	 alterations	 observed	 in	 animal	model	 are	 similar	 to	 human	 myocardial	 infarction.	ISO	was	administered	at	a	dose	of	85	mg/kg	s.c.	body	weight	[7].	Herbal	 drugs	 exhibit	 medicinal	 properties	 in	 the	treatment	of	heart	ailments	and	need	to	explores	to	identify	their	potential	application	in	prevention	and	therapy	of	human	ailments	and	also	used	to	treat	my-ocardial	infarction.	While	herbs	like	Moringa	olifera,	
Withania	somnifera	[9]	etc	are	helpful	in	the	treatment	of	cardiovascular	disorders.	WHO	 currently	 encourages,	 recommend	 and	 pro-mote	conventional	as	well	as	natural	remedies	in	the	national	 health	 care	 programmes,	 as	 they	 available	
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easily	at	low	cost,	comparatively	safe,	and	are	cultur-ally	acceptable.	The	usage	of	herbs	in	myocardial	in-farction	as	they	are	safe	and	alternative	medicine	[10].	Therefore	 the	 aim	 is	 to	 evaluate	 the	 potent	 cardio	protective	 activity	 of	 Ethanolic	 Extract	 of	 Pulicaria	
Wightiana	 (EEPW)	 in	 ISO	 induced	 cardiac	 necrosis	using	an	invivo	rodent	model.	
MATERIALS	AND	METHODS	
Plant	material:	
Collection	 of	 Leaves:	 Fresh	 leaves	 of	 Pulicaria	
Wightiana	 were	 collected	 from	Botanical	 garden	 of	PRRM	College	of	Pharmacy,	Kadapa,	and	Andhra	Pra-desh	 and	 authentified	 by	 Asst.	 Prof.	 Dr.	 K.	 Madava	Chetty	of	the	Department	of	Botany,	S.V.	University,	Tirupathi,	Andhra	pradesh.	
Preparation	of	extract:	The	dried	leaves	of	Pulicaria	
Wightiana	were	 taken,	 powdered	 in	 the	 grinder	 –mixer	then	obtain	a	coarse	powder	and	then	passed	through	40	mesh	sieve.	About	200gms	of	powder	was	extracted	by	using	70%	ethanol	by	maceration	pro-cess	up	to	24	hrs.	The	solution	was	filtered	through	with	the	whatmann	filter	paper	and	the	resultant	fil-trate	was	distilled	under	reduced	pressure	for	recov-ery	of	 solvent.	Then	 the	obtained	dried	extract	was	kept	in	a	desiccator	and	used	for	the	further	experi-ments.	
Experimental	 Animals:	 Male	 wistar	 albino	 rats	(180-230gm)	 procured	 from	 Raghavendra	 enter-prises	(Bangalore),	were	used	in	present	study.	The	animals	 housed	 in	 the	 clean	 propylene	 cages	 and	maintained	the		standard	conditions	(25±2ºC	such	as		relative	 humidity	 44	 -	 56%	and	12	 hours	 light	 and	dark	cycles		respectively)	and	fed	with	the	standard	rat	 diet	 	 (Mysore	 feeds,	 Bangalore)	 and	 purified	drinking	water	ad	 libitum	 for	 every	 1	week	 before	and	during	the	experiments.		Institutional	Animal	 Ethical	 Committee	 (IAEC)	 of	 P.	Rami	 Reddy	 Memorial	 College	 of	 Pharmacy	(1423/PO/Re/s/11/CPCSEA/102/03/2017)	 ap-proved	the	present	study.	
Assessment	of	cardio-protective	activity:	The	ex-perimental	animals	randomly	divided	into	5	groups	(n=6)	and	treated	for	the	duration	of	30	days	as	per	treatment	 schedule	 given	 in	 table	 no.3.	 Mi	 was	treated	by	administration	of	ISO	(85	mg/kg	s.c.)	 for	29th&	30th	days	with	an	interval	of	24	hrs[11].	
Collection	 of	 blood	 samples:	 The	 blood	 samples	were	 collected	 from	 retro-orbital	 venous	 plexus	 of	the	rats	without	any	agent	for	partition	of	serum,	at	end	of	the	experimental	period.	After	collecting	blood	in	eppendorf	tubes	they	were	kept	for	1	hour	time	at	the	room	temperature	and	the	serum	was	separated	by	 centrifugation	at	2000	 rpm	 for	15	min	and	 they	stored	 until	 analyzed	 for	 the	 different	 biochemical	parameters.		
Statistical	 analysis:	All	 the	 data	was	 expressed	 as	the	 mean	 ±	 S.E.M.	 Statistical	 significance	 between	
more	 than	 two	 groups	 was	 tested	 using	 one	 way	ANOVA	 followed	by	 the	Tukey	 test	 using	 computer	based	fitting	program	(Prism	graph	pad	7.0).	Statisti-cal	significance	was	set	accordingly.	
RESULTS	
Serum	cardiac	markers:	
Effect	on	CK	-MB:	The	result	had	shown	the	effect	of	EEPW	on	serum	CKMB	levels	in	normal	and	experi-mental	 groups.	 There	was	 significant	 (p<0.001)	 in-crease	 in	 serum	 CKMB	 levels	 in	 ISO	 control	 group	when	 compared	with	 normal	 group.	 	 The	 standard	group	receiving	Propranolol	(5	mg/kg)	shown	more	significant	decrease	 in	 serum	CK-MB	 levels	 and	 the	results	were	parallel	with	normal.	Amazingly	the	test-2	group	receiving	EEPW	(400	mg/kg)	showed	signif-icance	decrease	in	(p<0.01)	serum	CK-MB	levels	than	test-1	which	was	receiving	EEPW	(200	mg/kg).	
 
Figure 1: Effect of EEPW on CK –MB	
Effect	of	Lactate	dehydrogenase	(LDH):	The	result	had	shown	the	effect	of	EEPW	on	serum	LDH	levels	in	normal	and	experimental	groups.	There	was	signifi-cant	 (p<0.001)	 increase	 in	serum	LDH	 levels	 in	 ISO	control	group	when	compared	with	normal	group.			The	 test-1	which	was	receiving	EEPW	(200	mg/kg)	and	 test-2	which	was	receiving	EEPW	(400	mg/kg)	showed	significant	and	dose	dependent	decrease	 in	the	significance	(p<0.01)	of	serum	LDH	levels	when	compared	to	ISO	control	group.	
 
Figure 2: Effect of EEPW& EEPW on LDH	
Effect	 on	 Aspartase	 transaminase	 (AST)/	 SGOT:		The	result	had	shown	the	effect	of	EEPW	on	serum	AST	levels	in	normal	and	experimental	groups.	There	was	significant	(p<0.001)	increase	in	serum	AST	lev-els	in	ISO	control	group	when	compared	with	normal	group.			
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The	 test-1	which	was	receiving	EEPW	(200	mg/kg)	had	shown	less	significance	(p<0.05)	but	test-2	which	was	receiving	EEPW	(400	mg/kg)	(p<0.01)	showed	significant	 and	 dose	 dependent	 decrease	 in	 Serum	AST	levels	when	compared	to	ISO	control	group.	
 
Figure 3: Effect of EEPW& EEPW on SGOT	
Effect	on	Alanine	transaminase	(ALT)/	SGPT:	The	result	had	shown	the	effect	of	EEPW	on	serum	ALT	levels	in	normal	and	experimental	groups.	There	was	significant	(p<0.001)	increase	in	serum	ALT	levels	in	ISO	 control	 group	 when	 compared	 with	 normal	group.			Surprisingly	 the	 test-2	 which	 was	 receiving	 EEPW	(400	mg/kg)	had	shown	more	significance	(p<0.001)	than	test-1	which	was	receiving	EEPW	(200	mg/kg)	(p<0.01)	when	compared	to	ISO	control	group.	
 
Figure 4: Effect of EEPW& EEPW on SGPT	
Effect	on	Alkaline	phosphate	(ALP):	There	was	sig-nificant	(p<0.001)	increase	in	serum	ALP	levels	in	ISO	control	 group	 when	 compared	 with	 normal	 group.	The	result	had	shown	the	effect	of	EEPW	on	serum	ALP	levels	in	normal	and	experimental	groups.	
 
Figure 5: Effect of EEPW& EEPW on ALP	
Amusingly	the	test-2	group	which	was	receiving	both	EEPW	(400	mg/kg)	had	shown	significant	(p<0.001)	decrease	in	the	serum	ALP	levels	when	compared	to	ISO	control	group	 than	Test-1	group	which	was	 re-ceiving	EEPW	(200	mg/kg).	
LIPID	PROFILES	
Effect	 on	 serum	 cholesterol:	 The	 obtained	 result	pretense	the	effect	of	EEPW	on	serum	cholesterol	lev-els	 in	 the	normal	and	experimental	groups	 	Admin-istration	of	ISO	causes	fibrotic	changes	and	accumu-lation	of	fat,	this	can	be	observed	in	control	group	rats	because	 there	was	significant	 (p<0.001)	 increase	 in	the	 serum	 cholesterol	 levels	 in	 ISO	 control	 group	when	they	compared	with	the	normal	group.		The	 test-1and	 test-2	 which	 was	 receiving	 EEPW	showed	decrease	in	the	serum	cholesterol	levels.	But	test-2	 group	 which	 was	 had	 shown	 significant	(p<0.001)	 decrease	 in	 the	 serum	 cholesterol	 levels	when	compared	to	ISO	control	group.	
 
Figure 6: Effect of EEPW& EEPW on Cholesterol	
Effect	 on	 serum	 triglycerides	 (TG):	 The	 result	shows	the	effect	of	EEPW	on	serum	triglycerides	lev-els	in	normal	and	experimental	groups.	ISO	causes	in-crease	in	triglyceride	synthesis,	so	when	it	is	admin-istered	 in	 control	 group	 it	 leads	 to	 significant	(p<0.001)	increase	in	serum	triglycerides	levels.	Flavonoids	present	in	both	EEPW	caused	reduction	of	triglycerides.	 Test-2	 had	 shown	 more	 significant	(p<0.001)	decrease	in	the	serum	triglycerides	levels	when	 compared	 to	 ISO	 control	 group	 than	 test-1	which	was	receiving	EEPW	(200	mg/kg).	
 
Figure 7: Effect of EEPW& EEPW on Triglycerides	
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Effect	 on	 serum	HDL-cholesterol:	 The	 result	 had	shown	the	effect	of	EEPW	on	serum	HDL	levels	in	nor-mal	and	experimental	groups.	There	was	significant	(p<0.001)	increase	in	serum	HDL	levels	in	ISO	control	group	when	compared	with	normal	group.			The	 test-1and	 test-2	 which	 was	 receiving	 EEPW	showed	decrease	in	the	serum	HDL	levels	when	com-pared	 to	 ISO	 control	 group	 than	 individual	 admin-istration.	But	test-2	which	were	receiving	EEPW	(400	mg/kg)	showed	less	significance	(p<0.05)	in	the	se-rum	HDL	levels.	
 
Figure 8: Effect of EEPW& EEPW on HDL	
Effect	on	serum	LDL	levels:	The	result	shows	the	ef-fect	of	EEPW	on	serum	LDL	levels	in	normal	and	ex-perimental	 groups.	There	was	 significant	 (p<0.001)	increase	 in	 serum	 levels	 LDL	 in	 ISO	 control	 group	when	compared	with	normal	group.			The	test-1and	test-2	which	was	receiving	EEPW	(200	mg/kg)	 and	 EEPW	 (400	 mg/kg)	 respectively	 had	shown	significant	decrease	in	the	serum	LDL	levels.	Interestingly	 test-2	 group	 showed	 significant	(p<0.001)	 decrease	 in	 the	 serum	 LDL	 levels	 when	compared	to	ISO	control	group.	
 
Figure 9: Effect of EEPW& EEPW on LDL	
Effect	on	serum	VLDL	levels:	The	result	shows	the	effect	of	EEPW	on	serum	VLDL	levels	in	normal	and	experimental	 groups.	 There	 was	 significant	(p<0.001)	increase	in	serum	VLDL	levels	in	ISO	con-trol	group	when	compared	with	normal	group.	The	 test-2	 group	 which	 was	 receiving	 EEPW	 (400	mg/kg)	had	shown	significant	(p<0.001)	decrease	in	the	serum	VLDL	levels	when	compared	to	ISO	control	group	 than	 test-1	which	was	 receiving	 EEPW	 (200	mg/kg).	
 
Figure 10: Effect of EEPW& EEPW on VLDL	
Effect	on	weight	of	heart:	The	result	shows	the	ef-fect	of	EEPW	on	heart	weight	in	normal	and	experi-mental	 groups.	 There	was	 significant	 (p<0.001)	 in-crease	 in	 heart	weight	 in	 ISO	 control	 group	 due	 to	edema	when	compared	with	normal	group.		The	 test-1,	 2	 group	 animals	 which	 were	 receiving	EEPW	 (200	mg/kg	 &	 400	mg/kg)	 respectively	 had	shown	decrease	 in	heart	weight	when	compared	 to	ISO	control	group.	Interestingly	test-2	group	showed	significant	 (p<0.001)	 decrease	 in	 the	 heart	 weight	when	compared	to	ISO	control	group.	From	 the	 above	 observation	 it	 is	 noted	 that	 due	 to	presence	 of	 polyphenols,	 catechins,	 flavonoids	 and	other	constituents	 in	Pulciaria	Wightiana	 it	 leads	to	decrease	in	ischemia,	necrosis	and	increase	in	the	an-tioxidant	levels.		So	 it	 is	 confirmed	 that	 the	 administration	Pulicaria	
Wightiana	had	shown	decreased	incidence	of	MI	and	increase	in	the	cardio	protective	activity	when	com-pared	with	ISO	treated	group.	Further	investigations	like	exploring	mechanism	of	actions	as	well	as	isola-tions	of	responsible	phytochemicals	may	help	for	bet-ter	understanding.	
 
Figure 11: Effect of EEPW& EEPW on Heart Weight	
DISCUSSION	The	 present	 study	 was	 carried	 out	 to	 evaluate	 the	combined	 cardio	 protective	 activity	 of	 Puliaria	
Wightiana	against	Isoproterenol	(ISO)	induced	myo-cardial	infarction	(MI).	Pretreatment	to	the	different	groups	were	given	for	30	days	and	ISO	was	adminis-tered	at	last	two	days	with	an	interval	of	24	hrs.	Due	
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to	chronic	ionotropy	ISO	induces	MI.	Blood	was	col-lected	at	the	last	day	of	experimental	period	and	bi-omarkers	were	observed.	ISO	is	a	synthetic	catecholamine.	It	is	a	β-adrenergic	agonist	when	it	binds	to	β1	receptors	which	are	pre-sent	in	heart,	produces	stimulation	in	receptors	and	production	of	 calcium	 ions	 results	 in	 positive	 iono-tropic	 and	 chronotropic	 effects.	 On	 higher	 doses	 it	causes	 increase	 in	preload	and	after	 load	which	 in-creases	ischemia	leading	to	decrease	in	blood	supply	to	myocytes.	Due	 to	hypoxia	 the	myocytes	 tends	 to	die	on	prolonged	ischemia	it	leads	to	necrosis	of	tis-sue	(Sharma	and	Sharma	2007).	Upon	administration	of	ISO,	the	oxygen	demand	of	the	heart	increases	with	increase	in	ionotropic	effect	in	the	heart,	resulting	in	prolonged	 ischemia	 and	 glucose	 deprivation.	 The	cells	are	damaged	with	increased	muscle	contractil-ity,	which	 results	 in	 increasing	 the	 cell	membranes	permeability	 allowing	 cardiac	 enzymes	 to	 leak	 out	into	the	bloodstream.	
Elevation	of	cardiac	markers	in	plasma	is	one	of	the	criteria	being	used	for	the	diagnosis	of	acute	myocar-dial	 infarction.	 The	 cardiac	markers	 should	 be	 pre-sent	in	high	concentration	in	myocardium	and	should	be	absent	from	non-myocardial	tissues.	It	should	be	rapidly	released	into	the	blood	stream	at	the	time	of	myocardial	injury	and	there	should	be	a	direct	rela-tion	between	the	plasma	level	of	the	marker	and	the	extent	 of	 myocardial	 injury.	 The	 plasma	 diagnostic	marker	 enzymes	 are	 of	 important	 because	 of	 their	catalytic	activity	and	 tissue	specificity.	The	myocar-dial	cells	contain	many	cardiac	enzymes	like	CK-MB	and	lactate	dehydrogenase.	CK-MB	 is	 localized	 predominantly	 in	 the	 heart	 and	this	makes	 it	a	valuable	diagnostic	tool	 for	MI	since	damage	specific	 to	 the	myocardium	would	result	 in	elevation	of	 CK-MB	Cardiac	biomarkers	 are	protein	components	of	cell	structures	released	into	the	blood	stream	when	myocardial	injury	occurs	and	they	can	be	measured	in	the	systemic	circulation[12].		
Table 1:   Treatment schedule for assessing the benefits of EEPW against ISO induced MI 
S. 
No. Group 
No. of 
Animals Treatment 
Treatment period 
(Days) 
1 Normal 6 Vehicle (1% CMC, p.o.) 30 
2 Control 6 Isoproterenol (85 mg/kg rat, s.c.) 30 
3 Standard 6 Propranolol (5 mg/kg, p.o.) + Isoproterenol (85 mg/kg rat, s.c.) 30 
4 Test-1 6 EEPW (200 mg/kg p.o) + Isoproterenol (85 mg/kg s.c.) 30 
5 Test-2 6 EEPW (400 mg/kg p.o) + Isoproterenol (85 mg/kg s.c.) 30 
S.C. - Subcutaneous, P.O. – Per oral, EEPW- Ethanolic extract of Puliaria Wightiana 
Table 2: Effect of EEPW on Serum biomarkers 
Groups Treatment 
ON 31ST DAY 
CK-
MB(IU/L) LDH(IU/L) ALT(IU/L) AST(IU/L) ALP(IU/L) 
Normal Vehicle (1% CMC, p.o.) 
79.80 ± 
2.53 348.8 ± 8.57 29.83 ± 1.19 
28.83 ± 
1.24 53.17 ± 1.30 
Control 
Isoproterenol 
(85 mg/kg rat, s.c.) 
 
197.2 ± 
2.07### 
485.3 ± 
13.36### 
77.5 ± 
2.04### 
47.0 ± 
2.12### 
122.8 ± 
2.49### 
Standard 
Propranolol 
(5 mg/kg, p.o.) + 
Isoproterenol (85 
mg/kg rat, s.c.) 
 
93.04 ± 
2.24*** 
350.2 ± 
6.23*** 
33.83 ± 
1.35*** 
30.50 ± 
0.42*** 
55.3 ± 
3.94*** 
Test-1 
EEPW (200 mg/kg 
p.o) + Isoproterenol 
(85 mg/kg s.c.) 
 
179.9 ± 
6.0* 
400.2 ± 
19.31** 
43.00 ± 
5.80*** 
39.17 ± 
2.21* 
105.0 ± 
4.93*** 
Test-2 
EEPW (400 mg/kg 
p.o) + Isoproterenol 
(85 mg/kg s.c.) 
 
101.7 ± 
2.06*** 
359.2 ± 
9.77*** 
36.00 ± 
1.03*** 
31.67 ± 
0.42*** 
65.00 ± 
1.71*** 
All values are shown in mean ± SEM and n=6, ###, indicates p<0.001, when compared with normal group, *** 
indicates p<0.001, **   indicates p<0.01, * indicates p<0.05, when compared to control group. 
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LDH	plays	an	 important	 role	 in	cellular	 respiration,	the	 process	 by	 which	 glucose	 (sugar)	 from	 food	 is	converted	 into	 usable	 energy	 for	 cells.	 LDH	 isoen-zymes	 are	 five	 kinds	 of	 the	 LDH	 enzyme	 that	 are	found	 in	 specific	 concentrations	 in	 different	 organs	and	tissues.	LDH-1	is	found	in	the	heart	and	in	RBC.	Levels	of	LDH	peak	at	3–4	days	and	remain	elevated	for	up	to	10	days	in	MI.	Tissue	break	down	releases.		The	 results	were	 showed	a	 significantly	 increase	of	serum	 CK-MB	 and	 LDH	 levels	 in	 ischemic	 control	when	compared	with	normal	group.	Puliaria	Wighti-
ana	treated	individually	as	well	as	in	combination	had	shown	significant	and	dose	dependently	decrease	in		serum	CK-MB	and	LDH	 levels	when	compared	with	ischemic	control	group.	Interestingly,	effect	of	combi-nation	was	found	more	significant	than	individual				treatments.	Treatment	with	 standard	drug	 i.e.	 Pro-pranolol	 (5	mg/kg	p.o.)	 found	 to	be	restores	serum	CK-MB	and	LDH	levels	to	normal	level.	These	obser-vations	are	in	line	with	previous	studies	done	on	ISO	induced	ischemic	rats	treated	with	Andrographis	pa-
niculata[13],	Curcuma	longa	[14].	The	serum	enzymes	namely	AST,	ALT	and	ALP	serve	as	sensitive	indices	to	assess	the	severity	of	myocar-dial	infarction.	All	these	parameters	were	found	to	be	elevated	in	ISO	control	group	when	compared	normal	group.	 Puliaria	 Wightiana	 individual	 and	 combina-tion	treatment	showed	significant	decrease	of	these	parameters,	and	values	were	found	parallel	with	nor-mal	group.	Lipids	play	an	 important	role	 in	cardiovascular	dis-ease,	not	only	by	way	of	hyperlipidemia	and	the	de-velopment	 of	 atherosclerosis	 leading	 to	myocardial	infarction,	 but	 also	 by	 modifying	 the	 composition,	
structure	and	stability	of	cellular	membranes.	Hyper-cholesterolemia,	 high	 concentration	 of	 low-density	lipoprotein	 cholesterol,	 hyper	 triglyceridemia	 and	low	 high-density	 lipoprotein	 are	 accepted	 as	 inde-pendent	risk	factors	for	atherosclerotic	cardiovascu-lar	disease	and	mortality[15,16].	Significant	changes	in	the	 fatty	 acid	 composition	 of	 serum	 triglycerides,	cholesterol	 ester	 and	 phospholipids	 were	 also	 re-ported	in	acute	myocardial	infarction	condition[17].	
Puliaria	Wightiana	 treatment	 tends	 to	decrease	 the	levels	of	lipids.	But	test	-3	showed	potentiation	effect	on	decrease	in	the	cholesterol,	TG,	LDL,	VLDL	and	in-crease	 in	 the	HDL	 levels	 as	 compared	 to	 individual	treatments.	EEPW	had	shown	significant	decrease	in	cholesterol,	TG,	LDL	and	VLDL	levels.	Rats	treated	with	ISO	have	been	reported	to	undergo	increase	in	heart	weight	due	to	increase	in	water	con-tent	 and	 development	 of	 edema	 in	 intramuscular	spaces	culminating	in	extensive	necrotic	changes	and	invasion	 of	 inflammatory	 cells.	 The	 test-2	 group	EEPW	(400mg/kg)	had	shown	significant	decrease	in	heart	weight	due	to	presence	of	antioxidants	and	the	results	of	test-2	group	coincide	with	standard	group.		Flavonoids	 (catechins)	 the	 most	 common	 group	 of	polyphenols	plays	an	 important	role	as	antioxidant.	Flavonoids	decrease	the	free	radical	which	cause	oxi-dative	 stress,	 scavenge	 superoxide	 radicals	 and	hy-drogen	peroxide	produced	by	ISO	and	reduces	myo-cardial	damage.		Premna	serratifolia	rich	in	flavonoids	showed	cardioprotective	effect	in	ISO	induced	MI.	From	 the	 above	 observation	 it	 is	 noted	 that	 due	 to	presence	 of	 polyphenols,	 catechins,	 flavonoids	 and	other	 constituents	 in	 Puliaria	Wightiana	 it	 leads	 to	
Table 3: Effect of Pulicaria Wightiana.L on serum lipid profile 
Groups Treatment 
ON 31ST DAY 
CK-
MB(IU/L) LDH(IU/L) ALT(IU/L) AST(IU/L) ALP(IU/L) 
Normal Vehicle (1% CMC, p.o.) 
79.80 ± 
2.53 348.8 ± 8.57 29.83 ± 1.19 
28.83 ± 
1.24 53.17 ± 1.30 
Control 
Isoproterenol 
(85 mg/kg rat, s.c.) 
 
197.2 ± 
2.07### 
485.3 ± 
13.36### 
77.5 ± 
2.04### 
47.0 ± 
2.12### 
122.8 ± 
2.49### 
Standard 
Propranolol 
(5 mg/kg, p.o.) + 
Isoproterenol (85 
mg/kg rat, s.c.) 
 
93.04 ± 
2.24*** 
350.2 ± 
6.23*** 
33.83 ± 
1.35*** 
30.50 ± 
0.42*** 
55.3 ± 
3.94*** 
Test-1 
EEPW (200 mg/kg 
p.o) + Isoproterenol 
(85 mg/kg s.c.) 
 
179.9 ± 
6.0* 
400.2 ± 
19.31** 
43.00 ± 
5.80*** 
39.17 ± 
2.21* 
105.0 ± 
4.93*** 
Test-2 
EEPW (400 mg/kg 
p.o) + Isoproterenol 
(85 mg/kg s.c.) 
 
101.7 ± 
2.06*** 
359.2 ± 
9.77*** 
36.00 ± 
1.03*** 
31.67 ± 
0.42*** 
65.00 ± 
1.71*** 
All values are shown in mean ± SEM and n=6, ###, indicates p<0.001, when compared with normal group, *** 
indicates p<0.001, **   indicates p<0.01, * indicates p<0.05, when compared to control group. 
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decrease	in	ischemia,	necrosis	and	increase	in	the	an-tioxidant	levels.		So	 it	 is	 confirmed	 that	 the	 administration	 Puliaria	
Wightiana	had	shown	decreased	incidence	of	MI	and	increase	in	the	cardio	protective	activity	when	com-pared	with	ISO	treated	group.	
CONCLUSION	The	present	research	reveals	that	ISO	treatment	re-sulted	 in	 marked	 elevation	 in	 the	 level	 of	 cardiac	marker	enzymes	like	CK-MB,	AST,	ALT,	LDH	and	ALP	in	 serum,	 serum	 lipid	 profiles	 such	 as	 LDL,	 VLDL,	TGA,	 and	 Cholesterol	 and	 decreased	 levels	 of	 HDL	were	observed.	But	 treating	with	 the	 extract	 of	Pu-
licaria	wightiana	may	alter	these	cardiac	marker	en-zymes	and	lipid	profiles	and	helps	to	treat	the	coro-nary	artery	diseases.	Scientists	proved	that	catechins	and	flavonoids	possess	many	of	 the	structural	com-ponents	that	contribute	to	their	antioxidant	property.	From	the	above	observation	it	was	confirmed	that	Pu-
licaria	 Wightiana	were	 safe	 and	 highly	 effective	 in	preventing	cardiovascular	dysfunction	in	rats,	possi-bly	due	to	anti-oxidative	and	cardioprotective	prop-erties.	 Pulicaria	 Wightiana	 was	 enriched	 with	flavanoids,	 polyphenols	 and	 antioxidants	 acts	 by	scavenging	free	radicals	and	reduces	the	risk	of	oxi-dative	 stress,	 myocardial	 infarction.	 Thus	 Pulicaria	
Wightianacan	ameliorate	 the	effects	of	 ISO.	Present	efforts	are	directed	to	isolate	the	active	constituents	from	 various	 extracts	 of	 plant	 and	 elucidation	 of	mechanism	of	action.	
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